Xylem (XYL) Asset Writedowns and Impairment (2011 - 2025)

Xylem's Asset Writedowns and Impairment history runs 10 years deep, the most recent figure standing at $2.0 million for Q2 2025.

• In Q2 2025, Asset Writedowns and Impairment fell 84.62% year-over-year to $2.0 million; the TTM figure through Mar 2026 stood at $2.0 million (down 91.3% YoY), while the FY2025 annual figure was $8.0 million, up 14.29% from the prior year.
• Asset Writedowns and Impairment was $2.0 million for Q2 2025 at Xylem, down from $4.0 million in the prior quarter.
• In the past five years, Asset Writedowns and Impairment ranged from a high of $14.0 million in Q3 2022 to a low of $1.0 million in Q1 2021.
• Historically, Asset Writedowns and Impairment has averaged $3.9 million across 5 years, with a median of $1.5 million in 2021.
• The sharpest annual moves came in 2023 and 2024: Asset Writedowns and Impairment plunged 92.86% in 2023, then soared 500.0% in 2024.
• A 5-year view of Asset Writedowns and Impairment shows it stood at $1.0 million in 2021, then changed by 0.0% to $1.0 million in 2022, then changed by 0.0% to $1.0 million in 2023, then jumped by 500.0% to $6.0 million in 2024, then tumbled by 66.67% to $2.0 million in 2025.
• The last three Asset Writedowns and Impairment figures came in at $2.0 million (Q2 2025), $4.0 million (Q1 2025), and $6.0 million (Q4 2024), per Business Quant data.